News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2017 Shelley Wood July 31, 2017
News Daily News Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor L.A. McKeown July 26, 2017
News Daily News TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows Michael O'Riordan July 17, 2017
News Daily News More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis Michael O'Riordan July 03, 2017
News Conference News TVT 2017 Valve Leaflet Thrombosis: Treat It or Leave It Be? Shelley Wood June 19, 2017
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017
News Conference News TVT 2017 Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows Michael O'Riordan June 15, 2017
News Conference News TVT 2017 Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms Shelley Wood June 15, 2017
News Features Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts Caitlin E. Cox June 14, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Daily News Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions Michael O'Riordan June 06, 2017
News Conference News EuroPCR 2017 My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not Shelley Wood June 02, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2017 Shelley Wood June 01, 2017
News Conference News EuroPCR 2017 Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis Michael O'Riordan May 26, 2017
News Daily News Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke Todd Neale May 24, 2017
News Conference News EuroPCR 2017 TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years Caitlin E. Cox May 17, 2017
News Conference News EuroPCR 2017 Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters Michael O'Riordan May 17, 2017
News Conference News EuroPCR 2017 The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone Yael L. Maxwell May 17, 2017